Back |
home / stock / torc / torc message board
Subject | By | Source | When |
---|---|---|---|
I agree, it will be brief. | Rookiemove | investorshub | 05/12/2020 7:49:22 PM |
$TORC,Yep, take advantage of brief pullback here | TTIME | investorshub | 05/12/2020 7:41:21 PM |
Broke resistance today, greatness coming!! | Rookiemove | investorshub | 05/12/2020 7:40:04 PM |
PARABOLIC BABY!!! GO $TORC!! | Rookiemove | investorshub | 05/12/2020 3:10:31 PM |
RSI reset for next leg up. | Rookiemove | investorshub | 05/11/2020 7:24:04 PM |
I agree but think $TORC has alot of | TTIME | investorshub | 05/10/2020 7:59:47 PM |
Yeah. Just don't be greedy. There's that old | swingingRichard | investorshub | 05/10/2020 6:13:52 PM |
Thank you! Very promising. | Clemdane | investorshub | 05/10/2020 9:11:48 AM |
It's all good, profit is profit but I | TTIME | investorshub | 05/10/2020 4:52:08 AM |
The sad thing is that I got back | swingingRichard | investorshub | 05/09/2020 10:08:37 PM |
$TORC, a post from ST today >> | TTIME | investorshub | 05/09/2020 7:06:33 PM |
News, Short Squeeze, Breakout and More Instantly...
- Adicet Emerges as a Leading Allogeneic Gamma Delta T Cell Therapy Company Focused on Oncology - -Trading to Commence on September 16, 2020 on The Nasdaq Global Market Under Ticker Symbol “ACET”- MENLO PARK, Calif. and BOSTON, Sept. 15, 2020 (GLOBE NEWSWIRE) -...
MENLO PARK, Calif. , Aug. 5, 2020 /PRNewswire/ -- Adicet Bio, Inc., a privately-held biopharmaceutical company, today announced that it has received a $10 million milestone payment from Regeneron associated with ADI-002 meeting key preclinical development goals, in accordance with the t...
BOSTON, July 30, 2020 (GLOBE NEWSWIRE) -- resTORbio, Inc. (Nasdaq: TORC), a clinical-stage biopharmaceutical company developing innovative medicines that target the biology of aging to prevent or treat aging-related diseases, today provided a corporate update and reported financial results ...